Posts Tagged: Molly Shoichet
University Professor Molly Shoichet (ChemE, BME) has been named the inaugural Pamela and Paul Austin Chair in Precision and Regenerative Medicine. The chair, situated within the Department of Chemical Engineering & Applied Chemistry, was created in November 2023 via a gift from the The P. Austin Family Foundation.
The Institute of Biomedical Engineering (BME) at the University of Toronto is proud to announce that two of its doctoral candidates, David Li and Erica Floreani, have been awarded the prestigious Vanier Canada Graduate Scholarships for the 2024 cycle.
A research team at UHN's Donald K. Johnson Eye Institute in collaboration with the Institute of Biomedical Engineering at the University of Toronto (U of T) has discovered that transplanted retinal cells can share essential materials with host cells in the lab, offering a promising avenue for delivering therapies directly to damaged areas of the eye.
One of the CBRF-funded programs is the Biomanufacturing Hub Network, an immersive talent development program based at the University of Toronto led by U of T University Professor Molly Shoichet (ChemE, BME) along with Darius Rackus, an assistant professor of chemistry and biology at Toronto Metropolitan University, and Gilbert Walker, a professor of chemistry at U of T.
Professor Jeffrey Karp earned his PhD in collaboration with BME at the University of Toronto in 2004. Focusing on the philosophy of translation, he has since become a professor at Harvard Medical School, translating many of his research topics into commercially viable products – ranging from nasal sprays for disinfection to bioadhesive tapes used in surgery. Professor Karp recently published his first book, "LIT: Life Ignition Tools," discussing insights and advice gleaned from conversations with internationally renowned experts on building new habits.
University Professor Molly Shoichet has been elected a Fellow of the National Academy of Inventors (NAI).
A U of T Engineering research team has created a new platform that delivers multiple therapeutic proteins to the body, each at its own independently controlled rate. The innovation could help treat degenerative diseases such as age-related macular degeneration (AMD), the leading cause of vision loss for people over 50.
A team of U of T Engineering researchers, led by Professor Molly Shoichet (ChemE, BME, Donnelly), has designed a new way to grow cells in a laboratory that enables them to better emulate cancerous tumours.
Having exposure to biomedical sciences at a young age, Amber Xue continued her passion for clinical research at Molly Shoichet’s lab. She is also actively engaged in knowledge translation from academia to industry.
May 6, 2022 | A diverse group of 14 outstanding achievers will receive the university’s highest honour this June.
Showing 1 - 10 of 43 results